共 43 条
[1]
Gale R.P., Foon K.A., Acute myeloid leukemia: recent advances in therapy, Clinics in Hematology, 15, (1986)
[2]
Oshimi K., Oshimini Y., Akutsi M., Et al., Cytotoxicity of interleukin-2 activated lymphocytes for leukemia and lymphoma cells, Blood, 68, (1986)
[3]
Lanier L.L., Phillips J.H., Evidence for three types of human cytotoxic lymphocytes, Immunology Today, 7, (1986)
[4]
Rosenberg S.A., Lotze M.T., Muul L.M., A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone, New England Journal of Medicine, 316, (1987)
[5]
Leeuwenberg J.F.M., Spits H., Tax W.J.M., Capel P.J.A., Induction of cytotoxicity by monoclonal anti-T3 antibodies, Journal of Immunology, 134, (1985)
[6]
Trentin L., Pizzolo G., Feruglio C., Et al., Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission, Cancer, 64, (1989)
[7]
Gale R.P., Champlin R.E., How does bone marrow transplantation cure leukemia?, Lancet, (1984)
[8]
Weiden P.L., Flournoy N., Thomas E.D., Et al., Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts, New England Journal of Medicine, 300, (1979)
[9]
Gorin N.C., Aegerther P., Auvert B., Autologous bone marrow transplantation (ABMT) for acute leukaemia in remission: an analysis on 1322 cases, Bone Marrow Transplantation, 4, (1989)
[10]
O'Reilly R.J., Allogeneic bone marrow transplantation: current status and future directions, Blood, 62, (1983)